Valuation Integra LifeSciences Holdings Corporation
Stocks
IART
US4579852082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
21:00:00 08/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 13.41 USD | +3.15% |
|
-16.66% | +7.97% |
Company Valuation: Integra LifeSciences Holdings Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 5,674 | 4,683 | 3,405 | 1,750 | 967.4 | 1,043 | - | - |
| Change | - | -17.47% | -27.3% | -48.6% | -44.72% | 7.81% | - | - |
| Enterprise Value (EV) 1 | 6,707 | 5,670 | 4,605 | 3,285 | 2,563 | 2,532 | 2,328 | 2,107 |
| Change | - | -15.47% | -18.78% | -28.66% | -21.98% | -1.2% | -8.07% | -9.47% |
| P/E | 33.8x | 26x | 51.8x | -252x | -1.84x | 21.1x | 12.4x | 10.2x |
| PBR | 3.37x | 2.6x | 2.14x | 1.13x | 0.93x | 0.89x | 0.8x | 0.71x |
| PEG | - | 2.86x | -0.8x | 2x | -0x | -0x | 0.2x | 0.5x |
| Capitalization / Revenue | 3.68x | 3.01x | 2.21x | 1.09x | 0.59x | 0.63x | 0.61x | 0.59x |
| EV / Revenue | 4.35x | 3.64x | 2.99x | 2.04x | 1.57x | 1.52x | 1.35x | 1.19x |
| EV / EBITDA | 16.7x | 13.8x | 12.5x | 10.2x | 8.07x | 7.49x | 6.49x | 5.49x |
| EV / EBIT | 21.4x | 15.5x | 14x | 11.7x | 9.33x | 8.67x | 7.49x | 6.38x |
| EV / FCF | 25.4x | 25.5x | 63x | 132x | -82.5x | 22.6x | 13.7x | 11.1x |
| FCF Yield | 3.94% | 3.92% | 1.59% | 0.76% | -1.21% | 4.42% | 7.31% | 9.03% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.98 | 2.16 | 0.84 | -0.09 | -6.74 | 0.635 | 1.083 | 1.32 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,542 | 1,558 | 1,542 | 1,611 | 1,635 | 1,662 | 1,718 | 1,769 |
| EBITDA 1 | 400.7 | 411.3 | 369.7 | 322.2 | 317.5 | 337.9 | 358.5 | 383.9 |
| EBIT 1 | 314.1 | 366.6 | 329.1 | 281.1 | 274.8 | 291.9 | 310.8 | 330.2 |
| Net income 1 | 169.1 | 180.6 | 67.74 | -6.944 | -516.5 | 49.25 | 78.69 | 100.4 |
| Net Debt 1 | 1,033 | 986.7 | 1,200 | 1,535 | 1,596 | 1,489 | 1,285 | 1,064 |
| Reference price 2 | 66.99 | 56.07 | 43.55 | 22.68 | 12.42 | 13.41 | 13.41 | 13.41 |
| Nbr of stocks (in thousands) | 84,700 | 83,518 | 78,176 | 77,164 | 77,892 | 77,773 | - | - |
| Announcement Date | 23/02/22 | 22/02/23 | 28/02/24 | 25/02/25 | 26/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.12x | 1.52x | 7.49x | -.--% | 1.04B | |
| 28.83x | 3.87x | 14.97x | 2.61% | 170B | |
| 18.76x | 3.42x | 12.25x | 3.21% | 112B | |
| 21.56x | 4.24x | 14.8x | 1.3% | 106B | |
| 25.33x | 2.5x | 10.03x | 2.83% | 73.6B | |
| 17.6x | 0.2x | 12.85x | 0.74% | 61.32B | |
| 30.64x | 7.57x | 19.61x | 1.31% | 52.89B | |
| 35.22x | 3.41x | 11.67x | 2.15% | 49.78B | |
| 34.75x | 8.64x | 24.3x | -.--% | 40.43B | |
| 33.92x | 5.94x | 18.66x | -.--% | 31.85B | |
| Average | 26.77x | 4.13x | 14.66x | 1.41% | 69.98B | |
| Weighted average by Cap. | 25.91x | 4.00x | 14.62x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IART Stock
- Valuation Integra LifeSciences Holdings Corporation
Select your edition
All financial news and data tailored to specific country editions
